Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry

MLA

Sorrentino, S.Sartori, S.Baber, U.Claessen, B. E.Giustino, G.Chandrasekhar, J.Chandiramani, R.Cohen, D. J.Henry, T. D.Guedeney, P.Ariti, C.Dangas, G.Gibson, C. M.Krucoff, M. W.Moliterno, D. J.Colombo, A.Vogel, B.Chieffo, A.Kini, A. S.Witzenbichler, B.Weisz, G.Steg, P. G.Pocock, S.Urban, P.Mehran, R. Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..33c33682c1c792ba9104a9fae3ceb32a&authtype=sso&custid=ns315887.

APA

Sorrentino, S. S. S. B. U. C. B. E. G. G. C. J. C. R. C. D. J. H. T. D. G. P. A. C. D. G. G. C. M. K. M. W. M. D. J. C. A. V. B. C. A. K. A. S. W. B. W. G. S. P. G. P. S. U. P. M. R. (2020). Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry.

Chicago

Sorrentino, S. Sartori, S. Baber, U. Claessen, B.E. Giustino, G. Chandrasekhar, J. Chandiramani, R. Cohen, D.J. Henry, T.D. Guedeney, P. Ariti, C. Dangas, G. Gibson, C.M. Krucoff, M.W. Moliterno, D.J. Colombo, A. Vogel, B. Chieffo, A. Kini, A.S. Witzenbichler, B. Weisz, G. Steg, P.G. Pocock, S. Urban, P. Mehran, R. 2020. “Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events after Percutaneous Coronary Intervention: The PARIS Registry,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..33c33682c1c792ba9104a9fae3ceb32a&authtype=sso&custid=ns315887.